These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 30837720)

  • 1. Sildenafil's impact on male infertility: what has changed in 20 years?
    Scherzer ND; Le TV; Hellstrom WJG
    Int J Impot Res; 2019 Mar; 31(2):71-73. PubMed ID: 30837720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphodiesterase Type 5 Inhibitors for the Treatment of Erectile Dysfunction: Pharmacology and Clinical Impact of the Sildenafil Citrate Orodispersible Tablet Formulation.
    Scaglione F; Donde S; Hassan TA; Jannini EA
    Clin Ther; 2017 Feb; 39(2):370-377. PubMed ID: 28139291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treating erectile dysfunction and central neurological diseases with oral phosphodiesterase type 5 inhibitors. Review of the literature.
    Lombardi G; Nelli F; Celso M; Mencarini M; Del Popolo G
    J Sex Med; 2012 Apr; 9(4):970-85. PubMed ID: 22304626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sildenafil in postprostatectomy erectile dysfunction (perspective).
    Fode M; Jensen CFS; Østergren PB
    Int J Impot Res; 2019 Mar; 31(2):61-64. PubMed ID: 30837719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Current role of sildenafil in the management of erectile dysfunction].
    Akhvlediani ND; Matyukhov IP
    Urologiia; 2018 May; (2):142-146. PubMed ID: 29901310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct comparison of tadalafil with sildenafil for the treatment of erectile dysfunction: a systematic review and meta-analysis.
    Gong B; Ma M; Xie W; Yang X; Huang Y; Sun T; Luo Y; Huang J
    Int Urol Nephrol; 2017 Oct; 49(10):1731-1740. PubMed ID: 28741090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dosage forms of sildenafil in the management of erectile dysfunction].
    Grigoryan VA; Gazimiev MA; Demidko YL; Baiduvaliev AM
    Urologiia; 2018 Mar; (1):159-162. PubMed ID: 29634153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recreation use of phosphodiesterase type 5 inhibitors, the other side of erectile dysfunction.
    Fusco GM; Cirillo L; Mastrangelo F; Romano F; Di Mauro E; Cacace G; Spena G; Iannicelli A; Franzese CA; Mirone V; La Rocca R; Napolitano L
    Arch Ital Urol Androl; 2023 May; 95(2):11350. PubMed ID: 37254932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction: past, present and future].
    Gamidov SI; Ovchinnikov RI; Popova AY; Izhbaev SK
    Urologiia; 2017 Apr; (1):103-107. PubMed ID: 28394532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [SILDENAFIL CITRATE DOSE ADJUSTMENT FOR MEN WITH ERECTILE DYSFUNCTION: PERSONALIZED APPROACH].
    Korneev IA
    Urologiia; 2015; (4):108, 110-1. PubMed ID: 26665776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of phosphodiesterase type 5 (PDE5) inhibitors in treating erectile dysfunction after bilateral nerve-sparing radical prostatectomy.
    Cui Y; Liu X; Shi L; Gao Z
    Andrologia; 2016 Feb; 48(1):20-8. PubMed ID: 25684196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the Multifaceted Potential of Sildenafil in Medicine.
    Pușcașu C; Zanfirescu A; Negreș S; Șeremet OC
    Medicina (Kaunas); 2023 Dec; 59(12):. PubMed ID: 38138293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized open-label trial with a crossover comparison of sexual self-confidence and other treatment outcomes following tadalafil once a day vs. tadalafil or sildenafil on-demand in men with erectile dysfunction.
    Rubio-Aurioles E; Porst H; Kim ED; Montorsi F; Hackett G; Morales AM; Stuckey B; Būttner H; West TM; Huynh NN; Lenero E; Burns P; Kopernicky V
    J Sex Med; 2012 May; 9(5):1418-29. PubMed ID: 22429760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the association between erectile rigidity and treatment adherence with sildenafil.
    Mazzola CR; Deveci S; Teloken P; Mulhall JP
    J Sex Med; 2013 Jul; 10(7):1861-6. PubMed ID: 23253943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PDE5 inhibitors and male reproduction: Is there a place for PDE5 inhibitors in infertility clinics or andrology laboratories?
    Dimitriadis F; Kaltsas A; Zachariou A; Mamoulakis C; Tsiampali C; Giannakis I; Paschopoulos M; Papatsoris A; Loutradis D; Tsounapi P; Takenaka A; Sofikitis N
    Int J Urol; 2022 Dec; 29(12):1405-1418. PubMed ID: 36194789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [PDE-5 inhibitors: patients preferences].
    Efremov EA; Kasatonova EV; Melnik YI; Nikushina AA
    Urologiia; 2017 Jul; (3):120-126. PubMed ID: 28845950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An analysis of treatment preferences and sexual quality of life outcomes in female partners of Chinese men with erectile dysfunction.
    Li HJ; Bai WJ; Dai YT; Xu WP; Wang CN; Li HZ
    Asian J Androl; 2016; 18(5):773-9. PubMed ID: 26459780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The first-generation phosphodiesterase 5 inhibitors and their pharmacokinetic issue.
    Zucchi A; Costantini E; Scroppo FI; Silvani M; Kopa Z; Illiano E; Petrillo MG; Cari L; Nocentini G
    Andrology; 2019 Nov; 7(6):804-817. PubMed ID: 31350821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Serendipitous Story of Sildenafil: An Unexpected Oral Therapy for Erectile Dysfunction.
    Goldstein I; Burnett AL; Rosen RC; Park PW; Stecher VJ
    Sex Med Rev; 2019 Jan; 7(1):115-128. PubMed ID: 30301707
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.